Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study.

Alina Vrieling; Rebecca Hein; Sascha Abbas; Andreas Schneeweiss; Dieter Flesch-Janys; Jenny Chang-Claude

doi:10.1186/bcr2920

Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study.

Alina Vrieling
Rebecca Hein
Sascha Abbas
Andreas Schneeweiss
Dieter Flesch-Janys
Jenny Chang-Claude

Related Research units

II. Department of Medicine
Institute of Medical Biometry and Epidemiology

Abstract

Vitamin D has been postulated to be involved in cancer prognosis. Thus far, only two studies reported on its association with recurrence and survival after breast cancer diagnosis yielding inconsistent results. Therefore, the aim of our study was to assess the effect of post-diagnostic serum 25-hydroxyvitamin D [25(OH)D] concentrations on overall survival and distant disease-free survival.

Bibliographical data

Original language	English
Article number	4
ISSN	1465-5411
DOIs	https://doi.org/10.1186/bcr2920
Publication status	Published - 2011

pubmed	21791049